Impaired immune reconstitution post sequential high-dose chemotherapy and peripheral blood progenitor cell (PBPC) infusion.

被引：0
|
作者：
Stein, DT
Mackall, CL
Bare, CV
Brown, MR
Carter, CS
Casey, N
Yu, MY
Fleisher, TA
Leitman, SF
Shearer, GM
Wexler, L
Gress, RE
机构：
[1] NCI,DEPT TRANSFUS MED,BETHESDA,MD 20892
[2] NIH,DEPT CLIN PATHOL,BETHESDA,MD 20892
来源：
PEDIATRIC RESEARCH | 1996年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：962 / 962
页数：1
相关论文
共 50 条
  • [31] Peripheral blood stem cell mobilization for high-dose chemotherapy
    Demirer, T
    Bensinger, WI
    Buckner, CD
    JOURNAL OF HEMATOTHERAPY, 1999, 8 (02): : 103 - 113
  • [32] Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution
    Sandra Sauer
    Petra Pavel
    Anita Schmitt
    Martin Cremer
    Mark Kriegsmann
    Thomas Bruckner
    Karin Jordan
    Patrick Wuchter
    Carsten Müller-Tidow
    Katharina Kriegsmann
    BMC Cancer, 20
  • [33] High-dose chemotherapy with autologous peripheral blood progenitor cell transplantetion in patients with germ-cell tumors
    Nepomucká, J
    Boublikoviá, L
    Donátová Z, Z
    Charvát, J
    Kalanin, J
    Greplová, M
    Bártová, M
    Abrahámová, J
    BONE MARROW TRANSPLANTATION, 2002, 29 : S189 - S190
  • [34] Autologous peripheral blood progenitor cell (PBPC) support following high-dose therapy for patients with aggressive multiple myeloma (MM).
    Marit, G
    Faberes, C
    ConyMakhoul, P
    Boiron, JM
    Bernard, P
    Pigneux, A
    Puntous, M
    Vezon, G
    Broustet, A
    Reiffers, J
    BLOOD, 1996, 88 (10) : 515 - 515
  • [35] Immune reconstitution after high-dose chemotherapy (HDCT) followed by autologous peripheral stem cell transplantation (PBSCT).
    Reimer, P
    Kunzmann, V
    Weissinger, F
    Wilhelm, M
    BLOOD, 2000, 96 (11) : 402A - 403A
  • [36] High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease
    Weaver, CH
    Schwartzberg, L
    Li, W
    Hazelton, B
    West, W
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 715 - 721
  • [37] Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.
    Bauernhofer, T
    Schmid, M
    Stoeger, H
    Kasparek, AK
    Ploner, F
    Kuss, I
    Gilli, R
    Lanzer, H
    Samonigg, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S37 - S37
  • [38] EARLY HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANTATION IN PATIENTS WITH HIGH-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA
    BRUGGER, W
    GRAMATZKI, M
    KOLLMANNSBERGER, C
    KIEFER, T
    MERTELSMANN, R
    KANZ, L
    BLOOD, 1994, 84 (10) : A234 - A234
  • [39] High dose chemotherapy (HDC) supported by peripheral blood progenitor cells (PBPC) in patients with advanced ovarian cancer
    De Rosa, L
    Pescarollo, A
    Blandino, F
    Zoli, V
    Pescador, L
    Pandolfi, A
    Amodeo, R
    De Laurenzi, A
    ANNALS OF ONCOLOGY, 1998, 9 : 71 - 72
  • [40] BONE-MARROW RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - EFFECT OF GRAFT SIZE
    VANDERWALL, E
    RICHEL, DJ
    HOLTKAMP, MJ
    SLAPERCORTENBACH, ICM
    VANDERSCHOOT, CE
    DALESIO, O
    NOOIJEN, WJ
    SCHORNAGEL, JH
    RODENHUIS, S
    ANNALS OF ONCOLOGY, 1994, 5 (09) : 795 - 802
12345